Advancing Newborn Screening Toward Improving Pediatric Rare Genetic Diseases
Catherine Nester
A new initiative aims to screen newborns for nearly 400 genetic conditions
Catherine Nester
Catherine Nester, BSN, is vice president of physician and patient strategies at Inozyme Pharma. With more than 25 years of clinical and pharmaceutical experience, Catherine previously served in leadership roles at Incyte and Alexion Pharmaceuticals.